HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$14.10
Day range
$13.97 - $14.42
Year range
$10.80 - $35.40
Market cap
207.73M USD
Avg Volume
87.50K
P/E ratio
0.13
Dividend yield
-
Primary exchange
NASDAQ
Market news
Investopedia
1 day ago
Supermicro Stock Jumps to Lead S&P 500 Gainers Friday as JPMorgan Boosts
Rating
7.80%
1.10%
0.082%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 100.00K | -93.88% |
Operating expense | -51.40M | -759.31% |
Net income | -47.86M | 48.86% |
Net profit margin | -47.86K | -735.56% |
Earnings per share | -4.47 | — |
EBITDA | 18.82M | 121.40% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.60M | -45.09% |
Total assets | 180.77M | -41.29% |
Total liabilities | 47.18M | -82.15% |
Total equity | 133.58M | — |
Shares outstanding | 14.48M | — |
Price to book | 1.53 | — |
Return on assets | 22.48% | — |
Return on capital | 28.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -47.86M | 48.86% |
Cash from operations | -43.72M | 23.06% |
Cash from investing | -16.00K | 99.54% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -43.74M | 26.37% |
Free cash flow | 15.18M | — |
About
Founded
2024
Headquarters
Website
Employees
159
